Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,447 | -1,066 | -4,307 | -2,987 | -1,349 |
| Depreciation Amortization | 1,911 | 933 | 4,365 | 3,357 | 2,241 |
| Income taxes - deferred | N/A | 0 | -279 | 455 | 4 |
| Accounts receivable | 125 | 410 | 566 | 2,145 | 959 |
| Accounts payable and accrued liabilities | -703 | -320 | -2,413 | -2,785 | -2,459 |
| Other Working Capital | -2,286 | -1,325 | -41 | -473 | -2,377 |
| Other Operating Activity | 2,265 | 758 | 7,492 | 3,944 | 3,197 |
| Operating Cash Flow | $-135 | $-610 | $5,383 | $3,656 | $216 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -437 | -198 | -1,445 | -920 | -402 |
| Net Acquisitions | N/A | N/A | 1,417 | N/A | N/A |
| Other Investing Activity | -39 | -30 | -34 | -34 | -10 |
| Investing Cash Flow | $-476 | $-228 | $-62 | $-954 | $-412 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000 | 1,000 | 4,000 | 3,000 | 2,000 |
| Debt Repayment | -2,552 | -1,113 | -9,050 | -6,738 | -4,625 |
| Common Stock Issued | -77 | -155 | 182 | 80 | -9 |
| Financing Cash Flow | $-629 | $-268 | $-4,868 | $-3,658 | $-2,634 |
| Exchange Rate Effect | 368 | 109 | -1,601 | -443 | -283 |
| Beginning Cash Position | 5,596 | 5,596 | 6,744 | 6,744 | 6,744 |
| End Cash Position | 4,724 | 4,599 | 5,596 | 5,345 | 3,631 |
| Net Cash Flow | $-872 | $-997 | $-1,148 | $-1,399 | $-3,113 |
| Free Cash Flow | |||||
| Operating Cash Flow | -135 | -610 | 5,383 | 3,656 | 216 |
| Capital Expenditure | -437 | -198 | -1,445 | -920 | -402 |
| Free Cash Flow | -572 | -808 | 3,938 | 2,736 | -186 |